Since conception, nVision’s mission has been to develop safe and easy-to-use devices to aid clinicians in assessing tubal health.
Our first device, the Mako 7, uses patented microcatheter technology to access and collect cells from the fallopian tube during a minimally-invasive hysteroscopic procedure. These cell samples can then be further analyzed by cytologists.
Mako 7 received FDA 510K clearance in June 2016.
nVision’s team of engineers is leveraging our microcatheter technology platform to enable direct visualization of fallopian tubes during hysteroscopy. This device which is under development will incorporate a small-diameter fiberscope.